Top 5 Sliver Stocks To Buy For 2015

Top 5 Sliver Stocks To Buy For 2015: Fidia SpA (FDA)

Fidia SpA is an Italy-based company primarily engaged in the production of numerical controls and machine tools. The Companys activities are divided into three main business lines. In the High-speed Milling Systems, it is involved in the production and sale of milling heads kits and cutting-edge equipment. Through the Numerical Controls, Dives and Software sector, it is active in the manufacture of numerical controls for milling systems, as well as in the development and distribution of computer-aided design (CAD) and computer-aided manufacturing (CAM) software. The After-sales Service sector includes the provision of technical services, sale of spare parts and scheduled maintenance contracts. The Company operates in Germany, France, Brazil, China, Poland and India, among others. Advisors' Opinion:

• [By Patricio Kehoe]

  Despite recent anti-tobacco laws passed by the European Union and the Food and Drug Administration (FDA) in the U.S, the companys pricing power has helped maintain its margins. In 2012, for example, Phillip Morris hiked prices on its products in Russia, Germany, Belgium, Canada, France, Greece and Spain, among others. Although the necessary measure caused substantial volume declines in these countries, consumers rapidly became accustomed to the increased prices, and returned to their habitual product consumption. Given the success of this strategy, the firm is likely to rely on it in Japan for 2014, where taxes are expected to increase yet again by 8%, after the 40% spike in October 2010.

• [By Rahul Chattaraj]

  Every year more and more people are becoming health conscious and healthcare is one such industry which I feel can never be in slump. Its is just brilliant of Apple to embed a hardware in a smartphone which will be able to cash on this opportunity. The iPhone 5S already has the hardware components to support the Healthbook app and once the iOS 8 is released for the next iP! hone model and upgrades are available for the iPhone 5S, Apple will be poised to see huge surge in the demand for its devices. Certain incidents such as the top Apple executives meeting the US Food and Drug Administration (FDA), and former Mashimo Corp. Chief Medical Officer Michael O'Reilly joining Apple are clearly hinting that the companys mobile health dreams will very soon turn into reality.

• [By Steven Silver]

  Its Apremilast is currently under Food and Drug Administration (FDA) review for the anti-inflammatory condition, psoriatic arthritis, and has also shown promise in such indications as psoriasis and ankylosing spondylitis.

source from Top Penny Stocks For 2015:http://www.seekpennystocks.com/top-5-sliver-stocks-to-buy-for-2015-2.html